Seed Round · 2026
UNIVITAL™
Biotech from the Blue Frontier
An ocean-destroying pest holds the
blueprint for human longevity.
Heal People · Restore Oceans · Help the Planet
Scroll
Biotech from the Blue Frontier
An ocean-destroying pest holds the
blueprint for human longevity.
Red sea urchins live 200+ years with no signs of aging or cancer.
They regenerate tissue, spines, and organs across a two-century lifespan.
A unique class of compounds shaped by millions of years of evolution.
200+ Year Lifespan
Echinochrome A
Regenerative
Sea urchins in skincare? We laughed. Then we couldn't stop looking. A weird-before-it-was-obvious idea.
“We didn't go looking for this. It came to us. And then we couldn't unsee it.”
A clinically studied antioxidant, sold as a prescription drug abroad. Zero commercial supply in the West.
Mechanisms, studies & partners → see appendix
Urchin populations have exploded, stripping California kelp forests to barren rock.
Target: $5–15M in B2B contracts by Year 2–3. 200+ brands want novel marine ingredients. Sources in appendix.
Four founders across biochemistry, regulated skincare, and brand-building.
B.S. Biochemistry, UCSD (Phi Beta Kappa). Filed the UniVital patents.
Estée Lauder alum. Co-founded Kinesys Pharmaceutical (1993–2014).
40+ years CPG. 30+ years in regulated skincare.
Masters in Holistic Nutrition.
See scientific & industry partners in appendix.
Series A pricing to be determined.
Minimum investment $25,000
Heal People. Restore Oceans. Help the Planet.
Let's build the future of marine wellness together.
The depth behind the ten — science, market, moat, traction, terms & sources.
Professor at UC San Diego; Research Microbiologist, The Center for Marine Biotechnology & Biomedicine.
Marine Natural Product Chemist, Scripps Institution of Oceanography.
Over 40 years of experience formulating innovative, novel nutritional supplements.
Co-founder of BeyondBrands & founder of Innovation Nutrition Consulting; former VP Marketing at Robinson Pharma, with 30 years in supplement & functional food product development.
B2B, B2C, and DTC expertise. Co-founded several DTC brands. He's a pioneer, educator and speaker on utilizing AI in your business and life.
Specialties: branding and identity, business definition, core values and go-to-market execution.
Senior executive & consultant with 30+ years driving revenue growth in nutraceuticals, CPG & biotechnology; specialties: shareholder value, innovation and brand relevance.
Research collaborations with Harvard University, Dana-Farber Cancer Institute & Gloucester Marine Genomics Institute.
A clinically studied marine antioxidant, approved as the Rx drug Histochrome® abroad. The Western market has no commercial supply — UniVital is building the first scalable source.
Sea urchin spines and shells have been used in Traditional Chinese Medicine for hundreds — possibly thousands — of years.
The global supplement market is growing 7.6%–9.1% CAGR, yet marine bioactives remain under-commercialized despite strong clinical evidence.
Commercial demand can remove 1M+ tons of urchins annually — directly funding the restoration of California's kelp forests.
74.3% of Americans use dietary supplements (CDC). 73% of Gen Z will pay more for sustainable products — natural + sustainable is the fastest-growing CPG segment.
200+ supplement & cosmetic brands × $250K–$1M average annual ingredient contract = $50M–$200M near-term addressable. Marine category growing 6%–9% CAGR.
| Instrument | SAFE |
| Raise | $2M |
| Valuation Cap | $15M |
| Minimum | $25K |
| Next Round | Series A · 2027 |
Full clinical data & data room available upon request.
310-456-7877 · [email protected]
Full clinical data and additional studies available upon request · www.univital.org · 310-456-7877